INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo DYNA SERTRALINE 50
DYNA SERTRALINE 100

For full prescribing information refer to the package insert approved by the medicines regulatory authority.

SCHEDULING STATUS:
S5

PROPRIETARY NAME
(and dosage form):

DYNA SERTRALINE 50
DYNA SERTRALINE 100
tablets

COMPOSITION:
DYNA SERTRALINE 50: Each tablet contains sertraline hydrochloride equivalent to
sertraline 50 mg
DYNA SERTRALINE 100: Each tablet contains sertraline hydrochloride equivalent to sertraline 100 mg

ATC CLASSIFICATION:
no data

PRESENTATION/PACK SIZE:
no data

REGISTRATION NUMBER:
DYNA SERTRALINE 50: 43/1.2/0339
DYNA SERTRALINE 100: 43/1.2/0340

APPLICANT:
Lebasi Pharmaceuticals

MANUFACTURER:
LUPIN LIMITED, VERNA
INDUSTRIAL AREA, VERNA-SALCETTE, GOA, INDIA

AVAILABILITY:
Launched by: Pharma Dynamics
Date: Friday, July 25, 2014
For more information contact Pharma Dynamics on 0800 742 762 or Pharma Dynamics Customer Care Line 0860-PHARMA (742 762) should you require any further information.

Click here to visit the Pharma Dynamics website...
Contact: Shouqat Mugjenker, CNS Portfolio Product Manager
Telephone: +27 (0) 21 707 7050
E-mail: S.Mugjenker@Pharmadynamics.co.za

DATE OF REGISTRATION:
05 December 2013

SOURCE: Government Gazette -
STAATSKOERANT, 13 JUNIE 2014 No. 37727
NOTICE 405 OF 2014 - MEDICINES CONTROL COUNCIL

Date posted: July 2014


SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2014